National Cancer Institute/NIH/DHHS

Funding Organization

Awards Grant

  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Administrative Core
  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Pilot Project #1
  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Pilot Project #2
  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Training and Education
  • 3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership
  • 3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership - Investigating Race-Related Microbial Influences in Triple Negative Breast Cancer
  • 3D-Microtumor_GBM Xenoline Proband Modeling of Kinome-Directed Therapy
  • A Druggable Chromatin Modifier Pathway in HCC
  • A Genome-Wide Methylation Study of Epigenetic Contributions to Multiple Myeloma
  • A Novel Druggable Genetic Vulnerability Pathway in Melanoma
  • A Novel Epigenetic Immunotherapy for Ovarian Cancer Treatment
  • A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
  • A Phase I Study to Evaluate the Safety and Immunogenicity of HPV 16 L2 11-200
  • Active - Administrative Core - Comprehensive Cancer Center Core Support Grant
  • Active - Biostatistics and Bioinformatics - Comprehensive Cancer Center Core Support Grant
  • Active - Comprehensive Cancer Center Core Support Grant - Alabama HPV Vaccination Coalition Supplement
  • Active - Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics SF (Hudson Alpha)
  • Active - Comprehensive Genomics Shared Facility - Comprehensive Cancer Center Core Support Grant
  • Active - Data Safety and Monitoring - Comprehensive Cancer Center Core Support Grant
  • Active - Developmental Funds - Comprehensive Cancer Center Core Support Grant
  • Active - High Resolution Imaging - Comprehensive Cancer Center Core Support Grant
  • Active - Human Imaging - Comprehensive Cancer Center Core Support Grant
  • Active - Major Program Leader - Comprehensive Cancer Center Core Support Grant
  • Active - NCI Clinical Trial Reporting Program - Comprehensive Cancer Center Core Support Grant
  • Active - Planning and Evaluation - Comprehensive Cancer Center Core Support Grant
  • Active - Proteomics - Comprehensive Cancer Center Core Support Grant
  • Active - Protocol Review & Monitoring - Comprehensive Cancer Center Core Support Grant
  • Active - Protocol Specific Research Support - Comprehensive Cancer Center Core Support Grant
  • Active - Recruitment & Retention - Comprehensive Cancer Center Core Support Grant
  • Active - Self-Collection & HPV Testing in Unscreened Women: A Feasibility Study in Brazil - Comprehensive Cancer Center Core Support Grant
  • Active - Senior Leadership - Comprehensive Cancer Center Core Support Grant
  • Active - Small Animal Imaging - Comprehensive Cancer Center Core Support Grant
  • Active - Structural Bilology SF Molecular NMR - Comprehensive Cancer Center Core Support Grant
  • Active - Structural Biology SF X-Ray Crystallography - Comprehensive Cancer Center Core Support Grant
  • Active - Tissue Procurement - Comprehensive Cancer Center Core Support Grant
  • Active - Transgenic Animal/Embryonic Stem Cell - Comprehensive Cancer Center Core Support Grant
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - ADI Core
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Administrative Core
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Assessment Core
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Project 1
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Project 2
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Recruitment Core
  • Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health- Project 3
  • Admin. Supp to Strengthen NCI-Supported Comm. Outreach Capacity Through Comm. Health Educators (CHEs) of the NON
  • Armed Replicating Ad for Breast Cancer Bone Metastasis
  • BMT Survivor Study-2 (BMTSS-2)
  • Biological Chemistry of Reactive Nitrogen Species Signaling in Cancer Etiology
  • Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress
  • Biological Definition of FCRL Molecules in Malignancy
  • Biomechanics of the Stromal Regulation of DCIS
  • C-Src Kinase/Calmodulin Interaction: A Therapeutic Target for Pancreatic Cancer
  • CD147 as a Novel Target in Head and Neck Cancer
  • COMPLETED - Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
  • COMPLETED - Comprehensive Cancer Center Core Support Grant - Neuro-Oncology Program
  • COMPLETED - Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Biostatistics/Bioinformatics Shared Resource
  • Cancer Clinical Investigator Team Leadership Award
  • Cancer Prevention & Control Training Program
  • Cancer Prevention & Control Training Program
  • Cancer Prevention and Control Training Program
  • Canine Immuno Neurotherapeutics
  • Cellular and Biologic Origins in CLL
  • Cervical Cancer Derived Xenografts (PDX) and Organoid Raft Cultures to Evaluate Pathway Specific Therapeutic Agents.
  • Cervical Cancer Prevention in Latina Immigrants
  • Cervical Cancer Preventive Measures Based on HPV 16 Epigenome
  • Chemoprevention of Breast Cancer with Rexinoids that Inhibit Obesity-Induced Metabolic Syndrome
  • Collaborative Human Tissue Network
  • Combinatorial Approach for Reducing Invasive Potential of Melanoma Cells
  • Combinatorial Epigenetic-Based Prevention of Breast Cancer
  • Common Variable Immune Deficiency (CVID) Project
  • Completed - Comprehensive Cancer Center Core Support Grant - DNA Sequencing SF
  • Completed - Comprehensive Cancer Center Core Support Grant - HIV Malignancy
  • Completed - Comprehensive Cancer Center Core Support Grant - Micro Array SF
  • Completed - Comprehensive Cancer Center Core Support Grant - NCI Clinical Trials Reporting Program (CTRP)
  • Completed - Comprehensive Genomics Shared Facility - Comprehensive Cancer Center Core Support Grant
  • Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukemia
  • Comprehensive Cancer Center Core Support Grant
  • Comprehensive Cancer Center Core Support Grant
  • Comprehensive Cancer Center Core Support Grant
  • Comprehensive Cancer Center Core Support Grant
  • Comprehensive Cancer Center Core Support Grant
  • Comprehensive Cancer Center Core Support Grant - Adiministrative Core
  • Comprehensive Cancer Center Core Support Grant - Admin Supplements to Stimulate Research in Non-AIDS Defining Cancers (NADCs)
  • Comprehensive Cancer Center Core Support Grant - Admin Supplements to Stimulate Research in Non-AIDS Defining Cancers (NADCs) in Aging Populations
  • Comprehensive Cancer Center Core Support Grant - Administration
  • Comprehensive Cancer Center Core Support Grant - Administrative Core
  • Comprehensive Cancer Center Core Support Grant - Administrative Core
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplement to Stimulate Research in HIV/AIDS Cancer Research
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplement to Stimulate Research in HIV/AIDS Cancer Research
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplement to Support Participation in the Experimental Therapeutics Clinical Trials Network (ETCTN)
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplements to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators (CHEs)
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplements to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators (CHEs) of the National Outreach Network (NON)
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplements to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators (CHEs) of the National Outreach Network (NON)
  • Comprehensive Cancer Center Core Support Grant - Administrative Supplemet
  • Comprehensive Cancer Center Core Support Grant - Biostatistics and Bioinformatics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Biostatistics and Bioinformatics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Biostatistics and Bioinformatics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Biostatistics/Bioinformatics
  • Comprehensive Cancer Center Core Support Grant - Cancer Cell Biology Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Cell Biology Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Cell Biology Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Chemoprevention Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Chemoprevention Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Chemoprevention Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Clinical Investigator Team Leadership Award
  • Comprehensive Cancer Center Core Support Grant - Cancer Clinical Investigator Team Leadership Award (CCITLA)
  • Comprehensive Cancer Center Core Support Grant - Cancer Control and Population Sciences Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Control and Population Sciences Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Control and Population Sciences Program
  • Comprehensive Cancer Center Core Support Grant - Cancer Prevention and Control in Rural Alabama: Development of a Participatory and Integrated Action Plan
  • Comprehensive Cancer Center Core Support Grant - Cancer Prevention and Control in Rural Alabama: Development of a Participatory and Integrated Action Plan
  • Comprehensive Cancer Center Core Support Grant - Cancer Prevention and Control in Rural Alabama: Development of a Participatory and Integrated Action Plan 2.0
  • Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics
  • Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics
  • Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Data & Safety Monitoring
  • Comprehensive Cancer Center Core Support Grant - Development Funds
  • Comprehensive Cancer Center Core Support Grant - Developmental Funds
  • Comprehensive Cancer Center Core Support Grant - Developmental Funds
  • Comprehensive Cancer Center Core Support Grant - Developmental Funds
  • Comprehensive Cancer Center Core Support Grant - Early Phase Clinical Research
  • Comprehensive Cancer Center Core Support Grant - Early Phase Clinical Research
  • Comprehensive Cancer Center Core Support Grant - Expanding Our Cancer Prevention and Control Infrastructure to Reduce Cancer and Other Chronic Disease Health Disparities in the Deep South
  • Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Fabian Supplement (QM-MSP, Ki67, and Cytomorphology of RPFNa Specimens from High Risk Women)
  • Comprehensive Cancer Center Core Support Grant - Gene Expression
  • Comprehensive Cancer Center Core Support Grant - HIV-Associated Malignancies Supplement
  • Comprehensive Cancer Center Core Support Grant - High Field Molecular NMR Shared Facility
  • Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Facility
  • Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - High Resolution Microscopy (Imaging)
  • Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Inflammation, Immunology and Immunotherapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Inflammation, Immunology and Immunotherapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Inflammation, Immunology and Immunotherapeutics Program
  • Comprehensive Cancer Center Core Support Grant - Major Program Leaders
  • Comprehensive Cancer Center Core Support Grant - Mass Spectrometry and Proteomics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Mass Spectrometry and Proteomics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Mass Spectrometry and Proteomics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Mass Spectroscopy
  • Comprehensive Cancer Center Core Support Grant - Microbiome and Gnotobiotics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Microbiome and Gnotobiotics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Microbiome and Gnotobiotics Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Molecular Biology/Rec. Protein
  • Comprehensive Cancer Center Core Support Grant - Molecular NMR
  • Comprehensive Cancer Center Core Support Grant - NCI Clinical Trial Reporting Program (CTRP) Support
  • Comprehensive Cancer Center Core Support Grant - Neuro-Oncology Program
  • Comprehensive Cancer Center Core Support Grant - Neuro-Oncology Program
  • Comprehensive Cancer Center Core Support Grant - Pilot Projects
  • Comprehensive Cancer Center Core Support Grant - Planning & Evaluation
  • Comprehensive Cancer Center Core Support Grant - Planning and Evaluation
  • Comprehensive Cancer Center Core Support Grant - Planning and Evaluation
  • Comprehensive Cancer Center Core Support Grant - Planning and Evaluation
  • Comprehensive Cancer Center Core Support Grant - Population Health Assessment in Cancer Center Catchment Areas
  • Comprehensive Cancer Center Core Support Grant - Population Health Assessment in Cancer Center Catchment Areas
  • Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Prevalence and Genotype Distribution of Cervical and Oral HPV Infection in HIV+Brazilian Women
  • Comprehensive Cancer Center Core Support Grant - Proteomics
  • Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
  • Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
  • Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
  • Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
  • Comprehensive Cancer Center Core Support Grant - Protocol Review/Monitoring
  • Comprehensive Cancer Center Core Support Grant - Protocol Specific
  • Comprehensive Cancer Center Core Support Grant - Recruitment & Retention
  • Comprehensive Cancer Center Core Support Grant - Recruitment and Retention Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Recruitment and Retention Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Recruitment and Retention Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Self-Collection & HPV Testing in Unscreened Women: A Feasibility Study in Brazil
  • Comprehensive Cancer Center Core Support Grant - Senior Leadership
  • Comprehensive Cancer Center Core Support Grant - Structural Biology Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Structural Biology Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Structural Biology Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Tissue Procurement
  • Comprehensive Cancer Center Core Support Grant - Tissue Procurement Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Tissue Procurement Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Tissue Procurement Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Transgenic Animal
  • Comprehensive Cancer Center Core Support Grant - Transgenic Animal Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Transgenic Animal Shared Facility
  • Comprehensive Cancer Center Core Support Grant - Transgenic Animal Shared Facility
  • Comprehensive Cancer Center Core Support Grant - caBIG Technology Assessment and Implementation Planning
  • Contemporary Therapeutics for Anaplastic Gliomas
  • Contemporary Therapeutics for Anaplastic Gliomas - Administrative Core
  • Contemporary Therapeutics for Anaplastic Gliomas - Animal Models
  • Contemporary Therapeutics for Anaplastic Gliomas - Brain Tumor Tissue Core
  • Contemporary Therapeutics for Anaplastic Gliomas - Clinical Trials Core
  • Contemporary Therapeutics for Anaplastic Gliomas - Project #1
  • Contemporary Therapeutics for Anaplastic Gliomas - Project #2 - Death Receptor Antibody Therapy for Anaplastic Glioma
  • Contract Orientation Meeting with NCI, Office of Acquistions
  • Cooperative Human Tissue Network
  • Credentialing Murine Models for Glioblastoma Preclinical Drug Development
  • Cytochrome C Oxidase in Malignant Gliomas
  • Cytoplasmic Multimerization of the RNA-Binding Protein HuR is Oncogenic in Glioma
  • DNA Topoisomerase-Camptothecin Interactions
  • Death Receptor-Mediated Apoptosis and Therapy Strategies in Ovarian Cancer
  • Deciphering How Esco2 Loss Acts as a Penetrance Modifier
  • Deep South Network for Cancer Control
  • Deep South Network for Cancer Control
  • Determination of Mussashi 1/CD44v6 Signaling in Mesenchymal Glioma Stem Cells
  • Determining the Influence Genomic Instability During Embryogenesis has on Tumor Penetrance
  • Developing Novel Combination Therapies for Pancreatic Cancer
  • Developing Therapy for the Treatment of Cholangiocarcinoma
  • Development, Implementation, and Evaluation of a Smoking Cessation Intervention Tailored to Rural Young Adult African American Men: Toward Scalability
  • Dietary Intervention of Non-Classical Wnt Signaling
  • Discovery of Novel Drug Targets for Breast Cancer
  • Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response
  • Early Life Prevention of Breast Cancer with Combined Epigenetic Botanicals
  • Engineered HSV for the Treatment of Malignant Glioma
  • Engineered HSV for the Treatment of Malignant Glioma - Core A. Administrative Core
  • Engineered HSV for the Treatment of Malignant Glioma - Project 1
  • Engineered HSV for the Treatment of Malignant Glioma - Project 2 - Radiation Enhancement of HSV Anti-Tumor Effects
  • Engineered HSV for the Treatment of Malignant Glioma - Project 3 - Preclinical Evaluation of Oncolytic HSV for Anaplastic Glioma Therapy
  • Engineered HSV for the Treatment of Malignant Glioma - Project 4 - Lessons from the O.R.: Using Clinical Biologic Correlates to Inform HSV Trial Design
  • Engineered HSV for the Treatment of Malignant Gliomas - Core B (Animal Model) - Experimental Glioma Animal Models
  • Enhancing Physical Activity After Breast Cancer Diagnosis: Randomized Trial
  • Epigenetics of Tea Polyphenols in Cancer Prevention
  • Evaluating Bioactive Food Components in Obesity and Cancer Prevention
  • Exploring Effects of Weight Loss on Ductal Carcinoma In Situ
  • Exploring the Impact of Negative Energy Balance in Men with Prostate Cancer
  • FOXP3-microRNA146-NFkB Axis in Tumor Suppression
  • Find Your BEAT: Toolkit to Increase Physical Activity in Rural Cancer Survivors
  • Focal Adhesion Kinase (FAK) in Human Neuroblastoma
  • Food and Eating Behaviors of Head and Neck Cancer Patients
  • Gene-Engineered and Targeted Stem Cell Therapy for Myeloma
  • Glycan Control of Stem Cell-Associated Pathways in Pancreatic Cancer
  • Glycosylation-dependent Mechanisms Regulating Ovarian Tumor cell Phenotype
  • HHSN26100002 Efficacacy of a Multi-Antegen Vaccine in the Prevention of MethyInitrosourea-Introduced Mammary Cancers (ER+) in Female Sprague-Dawley Rats
  • HHSN26100003 Chemopreventive Effects in Both Standard Chow Diets and High Fat Diets of Known Positive and Negative Chemopreventative Agents Employing Both High Risk (But Histologically Normally) Mammary Epithelium and Mammary Cancers Including Correlative Biomarkers
  • HHSN26100004 TORFP IV/IV 2013-3 Evaluation of GLG-302, a STAT3 Antagonist in the Prevention of Mammary Cancer
  • HHSN26100005 TORFP IV/IV 2013-4 Efficacy of Metformin in the Methylnitrosourea-Induced Model EF+ Mammary Carcinogenesis when Animals are Placed on Different Diets: Standard Diet, High Fat Diet, and High Fructose Diet
  • HHSN26100006 TORFP 2014-3I Evaluation of the Prevention by Actoplus/Met (Pioglitazone and Metformin) of ER+ and ER- Mammary Cancer Occurring in Rodents on a High-Fat Diet
  • HHSN26100007 TORFP 2014-5I Effect of Bazedoxifene Either Alone or in Combination with an Aromatase Inhibitor or Conjugated Estrogens (CE) in the Prevention of Mammary Cancers
  • HPV Clearance by Folic Acid Supplementation
  • HPV Clearance by Folic Acid Supplementation
  • Harvest for Health in Older Cancer Survivors
  • Heparanase In Tumor Progression, Metastasis and Chemoresistance
  • Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy
  • Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy
  • Heparanase Regulation of Osteolysis in Multiple Myeloma
  • Heparanase Regulation of Tumor Host Interactions in Myeloma and Breast Cancer
  • IVR-Supported Interventions for Cancer Prevention in the Deep South
  • Identifying Outcome Mediators of Calorie Restriction Mimetic use in Renal Cancer
  • Imaging Guided Surgery Using Fluorescently Labeled Cetuximab
  • Imaging Guided Surgery using Fluorescently Labeled Cetuximab
  • Imaging for Assessment and Prediction of Response to Therapy for Triple Negative Breast Cancer
  • Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer
  • Integrated Smoking Cessation Treatment for Low Income Community Corrections
  • Intra-Tumor Heterogeneity in Colorectal Cancer Progression and Treatment Response
  • Loss of FLJ13639 Expression in Acute Leukemia
  • Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk
  • Maternal Epigenetic Dietary Effects on Early Breast Cancer Prevention
  • Maternal Epigenetic Dietary Effects on Early Breast Cancer Prevention
  • Maternal Epigenetic Dietary Effects on Early Breast Cancer Prevention
  • Mechanisms of Human Papillomavirus DNA Replication
  • Mechanisms of Human Papillomavirus DNA Replication
  • Mechanisms of Resistance to Cancer Therapeutics
  • Medical Record Abstraction for Pancreatic Cancer Survival Analyses
  • MicroRNAs for Monitoring Tumor Progression and Predicting Response to Therapy
  • Microbiome Based Approach to Identify the Progression Potential of CIN 2 Lesions
  • Microenvironmental Regulation Of Leukemia Stem Cells
  • Microenvironmental Regulation of Glioblastoma Angiogenesis via CHD7
  • Microenvironmental Regulation of Leukemia Stem Cells
  • Mitigating Long-term Treatment-related Morbidity in Childhood Cancer Survivors
  • Mitochondria and Carcinogenesis
  • Mitochondria and Mutagenesis
  • Mitochondria in Prostate Cancer Diversity
  • Mitochondrial DNA and Prostate Cancer in African Americans
  • Molecular Characterization of Myeloma and Related Asymptomatic Precursor States
  • Molecular Determinants of Breast Cancer Malignancy
  • Molecular Predictors of Post-Mastectomy Breast Cancer Loco-Regional Recurrence
  • Molecular Therapeutics for Anaplastic Gliomas
  • Molecular Therapeutics for Anaplastic Gliomas - Career Development
  • Molecular Therapeutics for Anaplastic Gliomas - Core A
  • Molecular Therapeutics for Anaplastic Gliomas - Core C
  • Molecular Therapeutics for Anaplastic Gliomas - Pilot Projects
  • Molecular Therapeutics for Anaplastic Gliomas - Project 3
  • Molecular Therapeutics for Anaplastic Gliomas - Project 4
  • Molecular Therapeutics for Anaplastic Gliomas - Project 4 Consortium
  • Molecular Therapeutics for Anaplastic Gliomas - Supplement for Ester Suswam
  • Molecular Therapeutics for Anaplstic Gliomas - Core D
  • Morehouse School of Medicine/Tuskegee University/Univ. of Alabama Cancer Center Partnership
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: (Admin Supplement) to Support Development of PDX at UAB CCC
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Administrative Core
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Bioethics Shared Resource
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Biostatistics/Bioinformatics Shared Resource
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Outreach Core
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Pilot Research Project: IMPaCT 2.0
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Planning and Evaluation Core
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Project 1: CD24-Dependent Inactivation of Mutant p53 in Metastatic Castration-Resistant Prostate Cancer
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Project 2: Molecular Regulation of Kaiso in Prostate Cancer
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Research Education Core
  • Multi-Modal Lysosomotropic Death Therapy for Malignant Peripheral Nerve Sheath Tumors
  • Multimodal Study Of Cognitive Impairment Following Radiation Therapy for Locally Advanced Head And Neck Cancer
  • Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
  • NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumors) Collaborative Agreement
  • NCTN Deep South Research Consortium
  • NCTN Deep South Research Consortium
  • NCTN Deep South Research Consortium
  • NCTN Deep South Research Consortium
  • Negative Impact of RNA Destabilizer Tristetraprolin on Glioma Growth
  • Novel Anti-HER3 Strategy for Pancreatic Cancer
  • Novel Combinatorial Therapeutic Approach for Prostate Cancer
  • Novel Fluorinated Amino Ester Prodrugs For PET Imaging Of Gliomas
  • Novel Heparanase Inhibitors for Cancer Therapy
  • Novel Role for Shed Syndecan 1 in Promoting an Aggressive Tumor Phenotype
  • Novel Role of Compensatory Proliferation in Human Brain Tumor
  • Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors
  • Nucleoporin NUP205-Driven Novel Pathway in Melanoma Tumor Growth and Metastasis
  • Obesity Affects Immunity to Kidney Cancer
  • Oncolytic Immunotherapy Using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients
  • Optical Imaging of Primary and Regional Melanoma to Guide Surgical Resection
  • Osteopontin and Microenvironment of Initiated Cells
  • PREVENT Cancer Preclinical and Drug Development Program
  • PREVENT Cancer Preclinical and Drug Development Program
  • PRMT1-Mediated Metabolic Reprogramming in Leukemia Progression
  • Participatory Design of a Text Message System to Support Community Health Advisor
  • Personalized Therapy for p16-deficient Melanoma
  • Pet Tumor and Proliferation Imaging Via Cationic Amino Acid Transport
  • Phase-Sensitive X-Ray Breast Tomosynthesis (R09-003)
  • Plumbagin in Combination with Vemurafenib for BRAF-Mutant Melanoma
  • Post-Transcriptional Regulation Requires Phosphorylation of HuR in Gliomas
  • Preclinical In Vitro and In Vivo Screening Assays for Cancer Preventive Agent Development
  • Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers
  • Preclinical in Vitro and In Vivo Agent Development Assays
  • Predictive Molecular Markers of Colorectal Cancer
  • Prevention of UV-Carcinogenesis Through DNA Methylation-Dependent Immunomodulation
  • Prevention of UV-Carcinogenesis through DNA Repair-Dependent Immunomodulation
  • Promoting Weight-Loss in African American Cancer Survivors in the Deep South
  • Prostate, Lung, Colo-Rectal and Ovarian (PLCO) Cancer Screening Trial
  • Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial - Prostate Cancer Progression in the PLCO Cancer Screening Trial
  • Protein Interactions Underlying Fas-Mediated DISC in Cholangiocarcinoma
  • Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer Survivors
  • Quantitative PET Imaging for Oncologic Immune Response Prediction
  • RHYTHM: Restoring Health in You (and Your Partner) Through Movement
  • RXR Rexinoids for Cancer Chemoprevention
  • RXR Rexinoids for Cancer Chemoprevention - Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents
  • RXR Rexinoids for Cancer Chemoprevention - Core 1: Administrative Core
  • RXR Rexinoids for Cancer Chemoprevention - Core 2: RXR Rexinoid Design and Synthesis
  • RXR Rexinoids for Cancer Chemoprevention - Core 3: Rexinoid Screening and Animal Core
  • RXR Rexinoids for Cancer Chemoprevention - Program Integration and Management
  • RXR Rexinoids for Cancer Chemoprevention - Project 1: Evaluation if UAB30 on Skin Cancer Biomarkers in Human Renal Transplant Recipients
  • RXR Rexinoids for Cancer Chemoprevention - Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents
  • RXR Rexinoids for Cancer Chemoprevention - Project 3: Molecular Targets of Rexinoid Action in Skin
  • Racial Disparities: Pain in Women Treated for Breast Cancer
  • Radiolabeled Antibodies Targeting LAT1 for Imaging and Therapy of Prostate Cancer
  • Regulation of Beta1 Integrin Glycosylation by Ras
  • Regulation of Polycomb Repressive Complex 1 by EZH2 Regulated microRNAs in Cancer
  • Regulation of the Kidney Cancer Epigenome by Oncometabolite L-2-Hydroxyglutarate
  • Research Training Program in Basic and Translational Oncology
  • Research Training Program in Basic and Translational Oncology
  • Research Training Program in Surgical Oncology
  • Research Training Program in Surgical Oncology
  • Research Training Program in Surgical Oncology
  • Resistance of CML Stem Cells to Imatinib (Gleevec)
  • Role of Fumarate Hydratase in Renal Hypoxia and Tumorigenesis
  • Role of Genetic Susceptibility in Therapy-Related Subsequent Malignancies
  • Role of Gut Microbe Composition in Psychosocial Symptom Response to Exercise Training in Breast Cancer Survivors
  • Role of Microbiota in Therapy to Ovarian Cancer
  • Role of NF-kB in Hematopoietic Stem Cells and Leukemia-Initiating Cell Formation
  • Role of NMI in Retarding Breast Tumor Growth
  • Role of Oncometabolite L-2 Hydroxyglutarate in Reprogramming Renal Cell Carcinoma Metabolism
  • Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression
  • Roles of Semaphorin Signaling in Breast Cancer Racial Disparities
  • Rural Breast Cancer Survivors Intervention
  • SPORE in Breast Cancer
  • SPORE in Breast Cancer - Administrative Core
  • SPORE in Breast Cancer - Biostatistics Core
  • SPORE in Breast Cancer - Career Development
  • SPORE in Breast Cancer - Diversity Supplement
  • SPORE in Breast Cancer - Pilot Projects
  • SPORE in Breast Cancer - Project 1
  • SPORE in Breast Cancer - Project 2
  • SPORE in Breast Cancer - Project 3
  • SPORE in Breast Cancer - Project 4
  • SPORE in Breast Cancer - Project 5
  • SPORE in Breast Cancer - Tissue Core
  • STRAP and Smad 7 Signaling in Colorectal Carcinomas
  • SUMOylation and Cell Sensitivity to Top1 Poisons
  • Sialylation-dependent Mechanisms Driving Pancreatic Cancer Progression
  • Sowing the Seeds of Health: A Program for Latinas
  • Surgical Oncology Research Training Program
  • T001 HHSN2610001 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Kick Off Meeting - Contract Orientation and Kick Off Meeting
  • T002 HHSN2610002 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Task Order 2015 E-02 - Evaluation of Agents/Protocols that Inhibity the Two Major Pathways Involved in Human Urinary Bladder Cancer [PI3K, EGFR] and Protocols to Reduce their Toxicity
  • T003 HHSN2610003 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Task Order 2015 E-07 - Evaluation of the Cancer Prevention Efficacy of GLG-302
  • T004 HHSN2610004 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Immunologic Effects of NSAIDs With and Without a Vaccine in Colon Cancer Prevention
  • T005 HHSN26100005 TORFP 2017-E04 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Evaluation of "Clinical-Ready" Agents (Bazedoxifene and Lapatinib) in Combination for the Prevention of ER+ and ER- Mammary Cancers
  • T007 HHSN26100007 TORRP-EZ-2018-E01 Evaluation of STAT-3 ANtagonists in the Prevention of Mammary Cancer
  • T008 HHSN26100009 TORFP 2018-E04 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Evaluating Whether a Concurrent Retinoid X Receptor Agonist Can Enhance the Efficacy of HER2-IGFPB2-IGFLR Vaccine in Eliminating Existing Ductal Carcinoma in Situ and Preventing Progression of Invasive Breast Cancer
  • T009 HHSN26100008 TORFP 2018-E03 Prevention of Urinary Bladder Cancer with Two "Clinically-Ready" Agents (Everolimus and Naproxen) when Administered in Combination
  • T010 HHSN26100010 TORFP 2018-E07 Preclinical Development of a Chemopreventive Agent, 4-Methylumbelliferone (4-MU)
  • T011 HHSN26100011 TORFP 2018-E08 Further Development of Multi-Antigen Vaccines for the Primary and Secondary Prevention of Bladder Cancer
  • TGF-beta Polymorphisms and Breast Cancer in Families
  • TGFBR1 Signaling in Colorectal Cancer
  • TORFP 2019-E03 75N91019D00019 75N91019F00130 Evaluation of Two Different Classes of Compounds (STAT3 Inhibitors and SERMs) for Prevention of Urinary Bladder Cancer
  • TORFP 2019-E04 75N91010D00019 75N91019F00132 Colorectal Cancer Prevention by Novel EPA Analogue TP-252 and Naproxen in FAP and Lynch Syndrone Models
  • TORFP 2019-E06 75N91019D00019 75N91019F00131 Further Development of Colovac, a Multi-Antigen Multi-Peptide Vaccine, for Colon Cancer Prevention
  • Targeted Therapy for Breast Cancer with Osteolytic Bone Damage
  • Targeted Treatment of Metastatic Gastroenteropancreatic Neuroendocrine Tumors
  • Targeting Metabolic Checkpoints in the Tumor Microenvironment to Boost Efficacy of Anti-CTLA-4
  • Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
  • Testing Scalable, IVR-Supported Cancer Prevention Interventions in the Rural Alabama Black Belt
  • The FGF18/FGFR4 Amplicon: Novel Therapeutic Biomarkers For Ovarian Cancer
  • The Interplay of Behavior, Environment, and Microbiota in Colorectal Cancer Risk
  • The Natural History of CMV-Related Hearing Loss and the Feasibility of CMV Screening as Adjunct to Hearing Screening in the Newborn
  • The Role of CK2 in Glioblastoma Development
  • The Role of Exosome Heparanase and miRNAs as Biomarkers for Myeloma
  • The Thrombospondin1-TGF-Beta Axis in Multiple Myeloma
  • Therapy of Pancreatic Cancer With 212Pb-Labeled B7-H3 Specific Ab and LDE225
  • Third International Meeting on Genetic Syndromes of the Ras/MAPK Pathway
  • Topical Chemoprevention of Skin Cancer Biomarkers
  • Tumorigenic Role of Mitochondria in African-American Women
  • UAB / UMN SPORE in Pancreatic Cancer
  • UAB / UMN SPORE in Pancreatic Cancer - Career Development
  • UAB / UMN SPORE in Pancreatic Cancer - Core A
  • UAB / UMN SPORE in Pancreatic Cancer - Core B
  • UAB / UMN SPORE in Pancreatic Cancer - Core C
  • UAB / UMN SPORE in Pancreatic Cancer - Core D
  • UAB / UMN SPORE in Pancreatic Cancer - Development
  • UAB / UMN SPORE in Pancreatic Cancer - Project 1
  • UAB / UMN SPORE in Pancreatic Cancer - Project 2
  • UAB / UMN SPORE in Pancreatic Cancer - Project 3
  • UAB / UMN SPORE in Pancreatic Cancer - Project 4
  • UAB Cancer Prevention and Control Training Program (T32)
  • UAB Cancer Research Experiences for Students
  • UAB Cancer Research Experiences for Students (CaRES)
  • UAB Comprehensive Cancer Center Early Stage Investigator Recruitment
  • Urinary Metabolites of Cranberry that Protect against Bladder Cancer
  • Utilizing microRNA-146a to Block Triple-Negative Breast Cancer Cell Colonization
  • Validating a Novel Biomarker of Clinical Progression and Survival in CLL
  • Validation of a Genomic Signature that Predicts for Sub-Optimal Debulking of Epithelial Ovarian Cancer
  • Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors
  • Wnt5a and TGF-beta in Mammary Development and Cancer
  • Zambian Cervical Cancer Research Capacity Initiative
  • rAAV Vaccine Vector